Barclays’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-142,257
| Closed | -$949K | – | 4401 |
|
|
2023
Q3 | $949K | Buy |
142,257
+27,030
| +23% | +$180K | ﹤0.01% | 2127 |
|
|
2023
Q2 | $1.04M | Buy |
115,227
+14,269
| +14% | +$129K | ﹤0.01% | 2125 |
|
|
2023
Q1 | $735K | Sell |
100,958
-77,540
| -43% | -$565K | ﹤0.01% | 2355 |
|
|
2022
Q4 | $1.3M | Buy |
178,498
+83,695
| +88% | +$610K | ﹤0.01% | 1928 |
|
|
2022
Q3 | $733K | Buy |
94,803
+77,674
| +453% | +$601K | ﹤0.01% | 2335 |
|
|
2022
Q2 | $116K | Buy |
17,129
+3,551
| +26% | +$24K | ﹤0.01% | 3404 |
|
|
2022
Q1 | $108K | Buy |
+13,578
| New | +$108K | ﹤0.01% | 3631 |
|